No Data
No Data
Nike Bosses Assure Progress in Reshaping Business as Q2 Earnings Sink
Insurance Companies Assure Speedy Claims For Flood Victims
Trump's Return Has Women Who Use $349 Smart Ring to Track Their Periods Panicking Over Privacy. Oura's CEO Wants to Assure Them.
Caris Life Sciences Showcases Data Demonstrating the Clinical Value of Clonal Hematopoiesis Identification and Subtraction in Liquid Biopsy to Improve the Accuracy of Treatment Recommendations
Gilead's Livdelzi (Seladelpar) Shows Sustained Efficacy And Long-Term Safety In Primary Biliary Cholangitis; 81% Achieve Biochemical Response By Month 30, 41% Reach ALP Normalization, And 27% Experience Near Resolution Of Itch In Phase 3 ASSURE Study
Express News | Gilead Sciences Inc - Livdelzi Shows 81% Efficacy in Phase 3 Assure Study